Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.03 AUD
Change Today 0.00 / 0.00%
Volume 663.6K
As of 1:27 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark J. Ostrowski

President of Phenogen Sciences Inc., Genetic Technologies Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Mr. Mark J. Ostrowski has been President of Phenogen Sciences Inc. at Genetic Technologies Limited since December 31, 2014. Mr. Ostrowski has been a Senior Vice President of Sales and Marketing at Phenogen Sciences Inc since September 7, 2012. Mr. Ostrowski is responsible for managing the U.S. sales. He served as Us Senior Vice President Sales & Marketing - Phenogen Sciences Inc. He served as the Chief Executive Officer and President of Sera Prognostics Inc. since April ...

Read Full Background

Corporate Headquarters*

60-66 Hanover Street
Fitzroy, Victoria 3065


Phone: 61 3 8412 7000
Fax: 61 3 8412 7040

Board Members Memberships*

There is no Board Members Memberships data available.


Yale University
Yale University

Other Affiliations*

Annual Compensation*

Total Annual CompensationA$299,828

Stock Options*

All Other CompensationA$6,591
Exercisable Options800,000
Unexercisable Options1,600,000
Total Number of Options2,400,000

Total Compensation*

Total Annual Cash CompensationA$306,419
Total Short Term CompensationA$299,828
Other Long Term CompensationA$6,591
Total Calculated CompensationA$367,080
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTG:AU A$0.03 AUD 0.00


Michael R. McMullen Chief Executive Officer, President, Director and Member of Executive Committee
Agilent Technologies Inc.
Colin Stephen Goldschmidt M.B., B.Ch., F.R.C.P.A., F.A.I.C.D.Chief Executive Officer, Managing Director, Executive Director, Member of Risk Management Committee and Chief Executive Officer of Douglass Hanly Moir Pathology
Sonic Healthcare Limited
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETIC TECHNOLOGIES LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at